hi this is a supply chain question can you please help me regarding this

PLEASE ANSWER THE FOLLOWING QUESTIONS: 1. Explain the concept of Supply Chain Management. 11. From the description in the case study, describe what do you thing is J&J's Supply Chain Model (network) including suppliers, channel partners, distribution centers, customers. (You can draw their SCM diagram to include with the description). 2. What is the major problem that J&J Supply Chain is facing in the cases study? 2.1. Why this represent a security risk for the organization? 3. Identify, what Technology Systems or Innovations J&J implemented in their Supply Chain to be more efficient. 3.1. Explain, how these Technology Systems or Innovations helped the company to comply with the government's requirements? 3:2 Explain, how these Technology Systems or Innovations can help the company to archive customer satisfaction? 4. Identify the major components of the Supply Chain Council SCOR Model and briefly describe each of the six SCOR processes. 4.1. Identify an example for each of the six process from the case study where J&J is applying the SCOR model (explain your rationality). s. Explain the following statements: 5.1. "SCM visibility decreases as one moves farther upstream to suppliers and supplier's supplier, or when companies use outsourcing". 5.2. "As firms become leaner and more technology dependent, disruptions can cause more serious problems than ever before" Drug manufacturers around the globe are preparing for one of the most vital and comprehensive challenges ever faced by the industry. The goal is total security of the world's drug supply, not just at the point of manufacturing but throughout the supply chain and the life cycle of these drugs. In concert with governmental agencies and regulatory bodies, this new challenge involves the pharmaceutical manufacturers as well as wholesalers, distributors, retailers, and suppliers. Additionally, this challenge will require the efforts of software, technology, and equipment suppliers. It will be pervasive, and it will require a major fundamental change in the way the pharmaceutical industry thinks about manages, and moves inventory For years, the pharmaceutical industry has been dealing with issues of counterfeit and diverted drugs. Despite the considerable investment on the part of the manufacturers and the FDA, a number of counterfeit products Page 484 continue to make it into the supply chain. These drugs pass through a complex system of distributors, brokers. and wholesalers making detection not only difficult but complicated. The Johnson & Johnson Family of Companies (J&J) is at the forefront of the effort to ensure the integrity of the drug supply. Through their planning, investment, and commitment. J&J has built and implemented one of the first systems to comply with new federal and global regulations that will protect their drug supply for the patients who use their products. years ahead of the mandated schedule. In the future every drug that passes through the entirety of the J&J supply chain will be serialized, and will be tracked at ench point along the way. Within their distribution centers, their creative and innovative approach relied on the agility of an adaptive software platform making the design and development quicker to implement, much less expensive and for less risky to their business than traditional alternatives. Their success positions